A Clinical Investigation of the Taperloc® Microplasty™ Hip System
Completed
- Conditions
- OsteoarthritisAvascular NecrosisRheumatoid Arthritis
- Registration Number
- NCT00699309
- Lead Sponsor
- Biomet Orthopedics, LLC
- Brief Summary
The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Taperloc® Microplasty™ Hip System.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 98
Inclusion Criteria
- Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis
- Rheumatoid arthritis.
- Correction of functional deformity.
- Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques.
- Revision of previously failed femoral head resurfacing component
Exclusion Criteria
Absolute contraindications include:
- infection,
- sepsis, and
- osteomyelitis.
Relative contraindications include:
- uncooperative patient or patient with neurologic disorders who are incapable of following directions,
- osteoporosis,
- metabolic disorders which may impair bone formation,
- osteomalacia,
- distant foci of infections which may spread to the implant site,
- rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram,
- vascular insufficiency, muscular atrophy, or neuromuscular disease.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Harris Hip Score 5 years
- Secondary Outcome Measures
Name Time Method Incidence of revision or removals 5 Years
Trial Locations
- Locations (4)
Low Country Bone & Joint Specialists
🇺🇸Beaufort, South Carolina, United States
Arthritis & Sports Orthopaedics
🇺🇸Sterling, Virginia, United States
Piedmont Orthopedics
🇺🇸Greenville, South Carolina, United States
Texas Center for Joint Replacement
🇺🇸Plano, Texas, United States